Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The claim that pricing is absent from FDA labeling is accurate; the label describes a single-dose, one-time intravenous infusion and does not provide price information.
Category Scores
Accurate Statements
Pricing information is not included in FDA-approved labeling for Zolgensma.
Label does not include pricing; no price or reimbursement details are cited. The Dosage and Administration section indicates a single-dose, one-time infusion.
Dosing information specifies a single-dose, one-time intravenous infusion.
Dosage and Administration section of the label.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
Pricing-related claim has no safety implications.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement